Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Aim of the study is to gain more knowledge about efficacy and safety of Neovasculgen® in
daily clinical practice and obtain information about the quality of life in patients treated
with Neovasculgen®.